Understanding Mental Health Needs and Gathering Feedback on Transcutaneous Auricular Vagus Nerve Stimulation as a Potential PTSD Treatment among 9/11 Responders Living with PTSD Symptoms 20 Years Later: A Qualitative Approach.
Understanding Mental Health Needs and Gathering Feedback on Transcutaneous Auricular Vagus Nerve Stimulation as a Potential PTSD Treatment among 9/11 Responders Living with PTSD Symptoms 20 Years Later: A Qualitative Approach.
复制标题
DOI：
10.3390/ijerph19084847
复制
发表时间：
2022-04-16
影响因子：
--
通讯作者：
Zanos, Theodoros P.
中科院分区：
文献类型：
--
作者：
Schwartz, Rebecca M.;Shaam, Pooja;Williams, Myia S.;McCann-Pineo, Molly;Ryniker, Laura;Debnath, Shubham;Zanos, Theodoros P.
关键词：
创伤后应激障碍（PTSD）仍然是世贸中心（WTC）9/11救援人员最常见的诊断之一。经皮耳迷走神经刺激（taVNS）是一种潜在的治疗创伤后应激障碍，因为它可以下调大脑中的活动，这是已知的与应激反应和过度觉醒。为了了解参与精神卫生保健的障碍和促进因素以及使用taVNS器械治疗PTSD症状的可行性和可接受性，在皇后区WTC健康计划中患有PTSD症状升高的患者中进行了一个焦点小组。焦点小组讨论被记录、转录和分析。出现了三个主题和子主题：（1）心理健康困难的持续流行和获得护理的系统性挑战;（2）对taVNS器械作为潜在治疗选择的积极接受，包括如何提高可用性的讨论;（3）关于提高与在试点临床试验中测试器械相关的研究方法的可行性和可接受性的反馈。这些发现强调了需要额外的治疗选择来减少这一人群的PTSD症状，并为taVNS的试点临床试验提供关键的形成阶段输入。
Posttraumatic stress disorder (PTSD) remains one of the most prevalent diagnoses of World Trade Center (WTC) 9/11 responders. Transcutaneous auricular vagus nerve stimulation (taVNS) is a potential treatment for PTSD, as it can downregulate activity in the brain, which is known to be related to stress responses and hyperarousal. To understand barriers and facilitators to engagement in mental health care and the feasibility and acceptability of using the taVNS device as a treatment for PTSD symptoms, a focus group was conducted among patients from the Queens WTC Health Program who had elevated symptoms of PTSD. The focus group discussion was recorded, transcribed, and analyzed. Three themes and subthemes emerged: (1) the continued prevalence of mental health difficulties and systematic challenges to accessing care; (2) positive reception toward the taVNS device as a potential treatment option, including a discussion of how to increase usability; and (3) feedback on increasing the feasibility and acceptance of the research methodology associated with testing the device in a pilot clinical trial. The findings highlight the need for additional treatment options to reduce PTSD symptoms in this population and provide key formative phase input for the pilot clinical trial of taVNS.
登录
查看更多内容
影响因子：
4.3
作者：
Chang JL;Coggins AN;Saul M;Paget-Blanc A;Straka M;Wright J;Datta-Chaudhuri T;Zanos S;Volpe BT
通讯作者：
Volpe BT
DOI：
10.3390/ijerph16091536
发表时间：
2019-05-01
影响因子：
--
作者：
Bellehsen, Mayer;Moline, Jacqueline;Schwartz, Rebecca M.
通讯作者：
Schwartz, Rebecca M.
影响因子：
3.3
作者：
Diminich ED;Clouston SAP;Kranidis A;Kritikos M;Kotov R;Kuan P;Carr M;Bromet EJ;Luft BJ
通讯作者：
Luft BJ
影响因子：
10.4
作者：
Herbert, Robin;Moline, Jacqueline;Levin, Stephen M.
通讯作者：
Levin, Stephen M.
影响因子：
--
作者：
Huang F;Dong J;Kong J;Wang H;Meng H;Spaeth RB;Camhi S;Liao X;Li X;Zhai X;Li S;Zhu B;Rong P
通讯作者：
Rong P